One example would be the basic recommendation I make to take the exposure assessments out of section 64. That would have the result of going across the board and allow us not to have these assumptions about safe levels of exposure built into our decision-making.
Another option to consider, if the committee didn't like that one, would be to include explicit reference to cumulative exposures, to do aggregate exposure assessments for substances that have what they call a similar “mode of action”. So for phthalates, for example, instead of taking the phthalates one by one, and for each risk assessment only including those exposures to that particular one, we would do what they call an aggregate exposure assessment because we know they're all acting together on our bodies.
You could try to parse all of that out for how to do better exposure assessments, but again my recommendation is not to do that, but to take the requirement for exposure out of section 64.